At a glance
- Originator Sankyo
- Class Antivirals
- Mechanism of Action CD4 antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 15 Aug 2001 No-Development-Reported for HIV-1 infections in Japan (Unknown route)
- 03 Jul 1997 New profile
- 03 Jul 1997 Preclinical development for HIV-1 infections in Japan (Unknown route)